The Myths and Reality of Dementia — Swampscott Senior Center

October 9, 2025

Section 1: Agenda

Welcome and Sponsor Introduction 00:00:00 — Senior Center welcome; introduction of Jill Rhodes from The Current in Beverly, sponsor of the day’s lunch.
Seaglass Village Introduction 00:03:25 — Isy Abrams, President of Seaglass Village, describes the organization’s mission, recent state legislative recognition, and co-sponsorship of the program.
Presentation: The Myths and Reality of Dementia 00:07:55 — Dr. Howard Abrams delivers the main educational presentation, covering:
- Definitions: Dementia vs. Mild Cognitive Impairment 00:09:42
- Types of Dementia (Alzheimer’s, Vascular, Lewy Body, Frontotemporal) 00:15:55
- Normal vs. Abnormal Forgetfulness (including video clip) 00:17:50
- Neuroscience of Alzheimer’s Disease (Lisa Genova TED Talk clip) 00:25:31
- Diagnostic Workup: Blood Tests, Genetic Testing, Imaging, Neuropsychological Testing 00:30:37
- Treatment Options: Cholinesterase Inhibitors, Anti-Amyloid Therapies 00:39:53
- Cautions: Supplements, Brain Games, and Unproven Products 00:44:09
- Modifiable Risk Factors (Lancet 2024 — 14 Lifestyle Factors) 00:45:50
Audience Q&A 00:50:54 — Questions on pets and cognition, education and risk, nutrition and sleep, cholinesterase inhibitor duration, lithium, heredity, neuroplasticity, language learning, and UTIs mimicking cognitive decline.

Section 2: Speaking Attendees

Heidi (Swampscott Senior Center Staff/Director): [Speaker 1] (opening remarks, 00:00–03:20)
Jill Rhodes (Sales Representative, The Current in Beverly): [Speaker 1] (00:35–00:48) and [Speaker 2] (00:59–02:20) — Note: automated transcription inconsistently tagged her.
Isy Abrams (President, Seaglass Village): [Speaker 3] (03:25–07:44)
Dr. Howard Abrams (Psychiatrist, Main Presenter): [Speaker 4] (07:55–08:47), then [Speaker 1] (09:42–onward through presentation and Q&A) — The automated speaker diarization merged him with the earlier Speaker 1 (Heidi).
Video Narrator (NIA Forgetfulness Clip): [Speaker 2] (18:00–19:06)
Lisa Genova (TED Talk Clip — Neuroscientist, MGH): [Speaker 3] (26:03–29:28)
Audience Members (Various): Tagged inconsistently as [Speaker 2], [Speaker 3], [Speaker 4], and [Speaker 5] during Q&A. Identified individuals include:
- Joan — Audience member with apparent audiology/hearing expertise, referenced by name by Dr. Abrams 00:47:00 and again at 01:00:49.
- Margaret — Former geriatric care manager, referenced by name at 01:01:51, asked about UTIs and cognitive changes.
- Other audience members asked about pets, education, nutrition, cholinesterase inhibitors, lithium, heredity, and Duolingo.

Section 3: Meeting Minutes

Heidi, the Swampscott Senior Center host, welcomed a full room and introduced Jill Rhodes from The Current in Beverly, a senior living community that sponsored the day’s lunch 00:00:06. Rhodes described The Current as a recently renovated former school building offering 86 apartments with independent living, assisted living, and memory care. She noted that rent includes three meals a day, utilities, laundry, housekeeping, and transportation within a 15-mile radius 00:01:26. Rhodes invited attendees to tour the facility and left brochures.

Heidi announced that Swampscott High School was taping the event for later posting on YouTube and the town website, and asked attendees to remain seated during the presentation and use the microphone for questions 00:02:24.

Seaglass Village Introduction

Isy Abrams, President of Seaglass Village, introduced the organization, which serves seniors in Marblehead, Swampscott, and Nahant, with plans to expand into Salem within the year 00:03:51. She displayed special appreciation awards received from both the Massachusetts House of Representatives and Senate at the Essex County Women’s Breakfast, noting that Seaglass Village was the only organization recognized for serving seniors 00:04:24. Abrams described Seaglass Village’s services, including volunteer drivers who help members get to appointments, and encouraged attendees to consider joining either as members or volunteers. The organization has over 100 members receiving services 00:07:08. She then introduced her husband, Dr. Howard Abrams, as the day’s featured speaker.

Presentation: The Myths and Reality of Dementia

Dr. Howard Abrams, a psychiatrist with long experience on the North Shore and at Salem Hospital, opened with humor, joking about the difference between being “volunteered” and “voluntold” 00:07:55. He established a warm, interactive tone that he maintained throughout the presentation, encouraging the audience to hold onto their sense of humor when dealing with serious subject matter.

Definitions and Historical Context. Dr. Abrams traced the term “dementia” back to 1797, with references in writings as far as the 13th century 00:10:20. He noted the term has been officially reclassified by the American Psychiatric Association as “Major Neurocognitive Disorder” (MND), distinguished from “Minor Neurocognitive Disorder” 00:11:07. He defined dementia as a general term for conditions causing cognitive decline that interferes with daily life — emphasizing that the functional impairment criterion is the critical diagnostic threshold 00:12:17.

Mild Cognitive Impairment (MCI). Dr. Abrams drew a careful distinction between MCI and dementia, noting that MCI involves cognitive decline beyond what is expected for age and education but without functional impairment 00:13:40. He explained that MCI falls on the Alzheimer’s spectrum but that 75–80% of people with MCI will not progress to Alzheimer’s disease 00:15:28. He illustrated with clinical anecdotes — a hospitalized woman who didn’t know the date but knew to ask a nurse, and patients who function well at home but become confused in unfamiliar hospital environments 00:12:30.

Types of Dementia. Dr. Abrams reviewed the major categories: Alzheimer’s disease (50–70% of cases), vascular dementia (characterized by a stepwise decline following strokes), dementia with Lewy bodies, frontotemporal dementia, and mixed presentations 00:15:55. He emphasized that these are distinct disorders with different underlying pathologies.

Normal vs. Abnormal Forgetfulness. A short video from the National Institute on Aging distinguished normal aging lapses (occasional bad decisions, missing a payment, temporarily forgetting the day, losing things) from Alzheimer’s warning signs (persistent poor judgment, inability to manage bills, losing track of dates, difficulty conversing, frequently misplacing items and being unable to find them) 00:17:56. Dr. Abrams then engaged the audience interactively, asking which memory lapses bothered them most. Responses included taking longer to recall things, forgetting names, difficulty initiating conversation, losing objects, getting distracted, finding the right words, and forgetting whether medication was taken 00:19:31. The exchange was lively and participatory, with the audience clearly relating to the examples.

Cognitive Domains — Decline and Preservation. Dr. Abrams presented evidence that measurable cognitive decline begins around age 60 across domains including processing speed, memory, learning, executive function, language, reasoning, and spatial ability 00:21:54. He shared a patient’s reframing technique: “I don’t think of words as lost — I think of them as hiding. When they’re ready to come out, they come out” 00:22:37. He then offered reassurance by discussing crystallized intelligence — language, vocabulary, verbal reasoning, and general knowledge — which remains stable or even improves with age 00:23:40.

Neuroscience of Alzheimer’s Disease. Dr. Abrams played a clip from Lisa Genova’s TED Talk explaining the amyloid hypothesis: neurons release amyloid beta, which normally gets cleared by microglia; when accumulation exceeds clearance, sticky amyloid plaques form, eventually triggering inflammation, tau tangles, and synaptic/cell death 00:26:03. Genova noted that plaque accumulation may begin by age 40, with a 15–20 year lag before clinical symptoms appear 00:28:02. Dr. Abrams cautioned that the amyloid hypothesis is not universally accepted and referenced the Nun Study, which found cases of high amyloid burden without clinical impairment and vice versa 00:35:27.

Diagnostic Workup. Dr. Abrams outlined the diagnostic pathway: (1) see your doctor — and bring someone with you 00:31:07; (2) routine blood tests to rule out reversible causes; (3) genetic testing (APOE alleles — E3 being most common, E4 increasing risk, E2 decreasing risk) 00:32:11; (4) imaging including CT, MRI, and amyloid PET scans (available at Salem Hospital for about 10 years but ordered selectively) 00:34:24; (5) neuropsychological testing for standardized cognitive assessment 00:37:27; and (6) emerging blood tests for amyloid and tau — 31 are in development but “not ready for prime time” per local neurologists, with too many false positives and negatives 00:38:06. He specifically warned against ordering these blood tests independently without clinical context 00:38:56.

Treatment Options. Dr. Abrams reviewed existing cholinesterase inhibitors (donepezil, galantamine, rivastigmine) and memantine, characterizing them candidly as modestly effective at best — “I’m zero for about 400” on seeing wonderful responses, though neurologists he consulted reported occasional good outcomes 00:40:09. He then discussed the newer anti-amyloid monoclonal antibody therapies (lecanemab/Leqembi and donanemab/Kisunla), FDA-approved since 2024, which clear amyloid via IV infusion 00:41:17. He noted they cost $30,000–$35,000 per year, have narrow insurance eligibility, require biweekly infusions and repeated imaging, and that local neurologists with about 30 patients in active treatment don’t expect to see significant results for 3–4 years 00:42:03. He expressed cautious optimism that future iterations — including subcutaneous delivery — will be more accessible and effective, noting current studies show 20–30% slower decline 00:43:09.

Cautions on Supplements and Brain Games. Dr. Abrams warned the audience about Prevagen, brain boosters, and computerized cognitive training programs, stating they do not meaningfully address dementia 00:44:11. He noted the FDA took action against Prevagen’s marketing claims and that many testimonials are paid 00:45:01. While brain games can improve performance on specific tasks, they don’t transfer to real-world cognitive function in people with advancing decline.

Modifiable Risk Factors. Citing a 2024 Lancet paper, Dr. Abrams presented 14 modifiable lifestyle factors that collectively can reduce dementia risk by nearly half 00:45:50. These span the lifespan: completing secondary education; addressing hearing loss (he called out an audience member, Joan, for expertise on this); managing LDL cholesterol; treating depression; preventing traumatic brain injury (he pointedly reminded cane users to carry them rather than leave them in the car); physical activity; blood sugar control; smoking cessation; blood pressure management; weight management; limiting alcohol (7 drinks/week for women, 14 for men); combating social isolation; addressing air pollution; and treating visual loss 00:46:44. He emphasized that while each factor individually contributes only 1–5%, together they can reduce risk by close to 50%.

Summary. Dr. Abrams concluded with four takeaways 00:49:49: (1) “Getting old isn’t for sissies” — his grandmother’s wisdom; (2) cognitive decline is inevitable but lifestyle changes can meaningfully reduce dementia risk; (3) MCI and dementia are distinct clinical diagnoses; and (4) rely on medical teams and science for diagnosis and treatment, with reason for hope in ongoing research.

Audience Q&A

The Q&A session was engaged and substantive, reflecting the audience’s personal connections to the topic.

Pets and cognition 00:51:02: An audience member asked whether pets help. Dr. Abrams affirmed the mood and companionship benefits but noted he was unaware of studies demonstrating a measurable impact on dementia risk.

Education and risk 00:51:39: An audience member asked Dr. Abrams to elaborate on the education factor. He clarified it was simply a statistical finding from the Lancet study — completing high school lowers risk by a small percentage, meaningful only in aggregate with other factors.

Nutrition and sleep 00:52:18: An audience member noted the omission of nutrition from the risk factors. Dr. Abrams acknowledged the oversight and added that healthy eating, along with adequate sleep (7 hours recommended), are important, cautioning against long daytime naps that disrupt nighttime sleep.

Cholinesterase inhibitor duration 00:53:15: An audience member asked whether continuing these medications beyond two years makes sense. Dr. Abrams said they are well-tolerated with few side effects and may extend independent living, citing evidence of delayed nursing home placement. He referenced a British National Health Service study in which patients, families, and physicians could not distinguish between those on medication and those on placebo, though testing showed slightly slower decline 00:54:12.

Lithium for dementia 00:56:04: An audience member shared a striking personal account of her sister’s dramatic cognitive improvement on low-dose lithium — going from severe memory loss to recalling decades of personal history. Dr. Abrams acknowledged emerging research on lithium but cautioned that distinguishing medication effects from natural MCI reversibility is difficult, and that lithium is not yet considered mainstream for dementia treatment 00:57:07.

Heredity 00:58:21: An audience member asked whether dementia is hereditary. Dr. Abrams explained the APOE allele system (E2 protective, E3 common/neutral, E4 risk-increasing) and noted that while genetic inheritance sets the stage, lifestyle factors remain modifiable. He mentioned early gene therapy research — “So far we have some very smart mice” — and emphasized that genetic risk is not deterministic 00:58:48.

Neuroplasticity 01:00:18: Joan, an audience member, offered a “four-lane highway” analogy for cognitive reserve — education and engagement build extra lanes, so losing one is less catastrophic. Dr. Abrams affirmed this as neuroplasticity, noting the brain peaks at about 22 years of age in cell count but can retrain functions through alternative neural pathways 01:01:09.

Language learning apps 01:02:02: An audience member asked about Duolingo’s impact. Dr. Abrams said keeping the brain active through language learning, new skills, and cultural engagement maximizes remaining function and promotes socialization, though it cannot guarantee dementia prevention.

UTIs and cognitive changes 01:02:47: Margaret, a former geriatric care manager, noted that urinary tract infections frequently cause sudden cognitive changes in older adults and that hospitals don’t always check for them first. Dr. Abrams strongly agreed, emphasizing the importance of experienced caregivers who recognize that acute confusion may signal a treatable infection rather than progressive dementia 01:03:07.

Section 4: Executive Summary

A Packed Room for an Urgent Topic

The Swampscott Senior Center drew a full house on October 9, 2025, for an educational presentation on dementia — a topic of direct personal relevance to the audience. The event, co-sponsored by Seaglass Village and The Current in Beverly, featured Dr. Howard Abrams, a longtime North Shore psychiatrist, delivering a wide-ranging talk that balanced clinical rigor with accessibility and humor.

Key Takeaways for Residents

Dementia is not monolithic. Dr. Abrams emphasized that “dementia” encompasses multiple distinct disorders — Alzheimer’s disease (the most common, at 50–70% of cases), vascular dementia, Lewy body dementia, and frontotemporal dementia — each with different causes, progressions, and treatment implications. Critically, he distinguished mild cognitive impairment (MCI) from dementia: MCI involves noticeable cognitive changes that do not impair daily functioning, and 75–80% of MCI cases do not progress to Alzheimer’s 00:15:28. This distinction is significant for the many audience members who expressed concern about everyday memory lapses.

New treatments offer cautious hope. Anti-amyloid monoclonal antibody therapies (lecanemab and donanemab), approved in 2024, represent the first treatments that target the underlying biology of Alzheimer’s rather than just managing symptoms 00:41:17. However, Dr. Abrams was candid about limitations: they are expensive ($30,000–$35,000/year), require burdensome treatment regimens, have narrow insurance eligibility, and local neurologists don’t expect to see significant results for 3–4 years. Still, they show a 20–30% slowing of decline, and next-generation delivery methods (subcutaneous injection) may improve accessibility.

Lifestyle modifications are the most actionable intervention. The presentation’s most empowering message was that 14 modifiable risk factors — from hearing loss and depression to physical activity and social engagement — can collectively reduce dementia risk by nearly half 00:45:50. For Swampscott seniors, this reinforces the value of institutions like the Senior Center and Seaglass Village, which combat social isolation and promote engagement.

Beware of unproven products. Dr. Abrams specifically warned against Prevagen and similar supplements, noting FDA action against misleading marketing claims, as well as computerized brain training programs that improve game-specific performance but do not transfer to real-world cognitive function 00:44:11.

Community Resources Highlighted

Seaglass Village, serving Swampscott, Marblehead, and Nahant, was highlighted as a resource for seniors seeking to age in place, offering volunteer transportation and social programming. President Isy Abrams noted the organization’s recent state legislative recognition and its expansion plans into Salem 00:04:07. Essex Neurology in Peabody was identified as a local resource for neurological referrals, with new clinicians available to reduce wait times 00:36:30.

Section 5: Analysis

An Effective Blend of Authority and Accessibility

Dr. Abrams proved an adept communicator for this audience, deploying self-deprecating humor (“I’m zero for about 400”), clinical anecdotes, and interactive audience engagement to sustain attention through dense medical content. His opening joke about being “voluntold” by his wife to present — and Isy Abrams’ cheerful confirmation — established an intimacy that allowed the audience to engage openly with a topic many clearly found personally urgent. The Q&A session, which touched on highly personal subjects (a sister’s dementia, fears about heredity, confusion about medications), demonstrated that Dr. Abrams had created a safe space for candid discussion.

Candor as a Strength

Perhaps the most notable feature of the presentation was Dr. Abrams’ willingness to be transparent about the limits of current medicine. His assessment of cholinesterase inhibitors — “I’m zero for about 400 on wonderful responses” 00:40:22 — was strikingly honest for a prescribing physician. Similarly, his characterization of emerging blood tests as “not ready for prime time” 00:38:27 and his warning against ordering them without clinical context served as a practical public health message in an era of direct-to-consumer medical testing. This candor likely enhanced his credibility when delivering the more optimistic messages about lifestyle modification and future therapies.

The Audience as Participants, Not Passive Recipients

The interactive format — Dr. Abrams soliciting audience members’ most bothersome memory lapses, calling on Joan by name for hearing loss expertise, and fielding Margaret’s clinical insight about UTIs — transformed what could have been a lecture into a community conversation. The audience’s responses revealed deep engagement: the woman who shared her sister’s dramatic improvement on lithium, the practical questions about medication duration, the concern about heredity. These exchanges demonstrated that for many attendees, dementia is not an abstract medical topic but a present reality in their families and their own fears about aging.

Community Infrastructure as Dementia Prevention

An implicit but powerful theme ran through the entire event: the Swampscott Senior Center and Seaglass Village are themselves dementia-prevention infrastructure. Dr. Abrams’ emphasis on social isolation as a modifiable risk factor 00:49:08 directly validates the mission of both organizations. The full room — and the range of questions from attendees who were clearly regular participants in Senior Center programming — suggests these institutions are functioning as intended. Isy Abrams’ description of Seaglass Village’s volunteer driver program and educational programming, combined with state legislative recognition, positions the organization as an increasingly formalized part of the region’s aging-in-place support network.

Tensions Between Hope and Realism

Dr. Abrams navigated a difficult rhetorical balance throughout: acknowledging that cognitive decline is inevitable while arguing that it is partially manageable; expressing excitement about new anti-amyloid therapies while noting their current limitations; endorsing mental engagement while disclaiming brain games. His most effective synthesis came in the 14 modifiable risk factors — individually modest (1–5% each) but collectively powerful (up to 50% risk reduction) 00:49:33. This framing gave the audience concrete, actionable steps without overpromising, and it aligned with the event’s overall message: aging with dementia risk is not about finding a silver bullet but about aggregating small advantages across lifestyle, medical care, and community connection.

A Note on the Lithium Exchange

The most medically provocative moment of the Q&A was the audience member’s account of her sister’s dramatic improvement on low-dose lithium 00:56:04. Dr. Abrams handled this delicately — acknowledging the emerging research while noting the difficulty of distinguishing drug effects from natural MCI reversibility. This exchange illustrates a broader challenge in dementia communication: personal testimonials carry enormous emotional weight, but they cannot substitute for controlled evidence. Dr. Abrams’ response modeled how to honor individual experience without endorsing unproven interventions — a balance particularly important for an audience likely to encounter similar stories and products.

2025-10-09: Myths And Reality Of Dementia